Active Share (vs S&P 500): 80.6%
· vs QQQ: 81.3%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
+3.9%
· vs SPY
+1.8%
· Prev Value $2.99B
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
-0.4%
· vs SPY
-2.6%
· Latest Value $2.96B
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, Patient Capital Management, LLC disclosed 39 equity positions with a combined reported value of $2.96B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.3% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q3 2026 were RPRX ($199.71M), C ($179.92M), GOOGL ($178.40M). By sector, the heaviest allocations are Consumer Discretionary 24.6%, Technology 22.5%. Versus the prior quarter, allocation shifted toward Technology (+5.0pp), Financials (+1.9pp) and away from Other (-0.9pp), Health Care (-1.2pp).
Versus the prior quarter, Patient Capital Management, LLC opened 3 new positions, trimmed 23 and fully exited 3, a turnover rate of 69.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.
The largest new positions opened in Q3 2026 were AVGO ($83.74M), IDRV ($271.79K), XHB ($260.12K).
Of the 3 positions fully exited versus the prior quarter, the largest were ILMN ($60.72M), PLAY ($2.33M), SPY ($791.60K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest Samantha McLemore buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Patient Capital Management, LLC is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $2.99B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Largest position: RPRX (ROYALTY PHARMA PLC) at 6.8%
Average position size: $76.65M
Sector Tilt
Consumer Discretionary 28.4%
Health Care 19.9%
Financials 17.9%
(classified holdings cover 96% of value)
Quarterly Activity
Q2 2026: 2 new, 10 added, 18 reduced, 2 exited
9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure across 7 of its top-10 holdings (notably Financials, Health Care, and large-cap Tech), while adding to 2 smaller positions (QXO, CHYM) and holding NVDA/META. This suggests a cautious tilt toward smaller-cap, high-growth names (QXO +53% shares) and fintech (CHYM +15.9%) amid broader trimming of blue chips.
2. Key moves:
- Reduced: RPRX (flat weight, -4.9% shares), C (-1.0% shares), GOOGL (-1.4% shares), AMZN (-0.6% shares), UNH (-2.7% shares), PGEN (-5.7% shares).
- Added: QXO (+53.2% shares), CHYM (+15.9% shares).
- Held: NVDA (flat shares), META (+0.4% shares).
3. Portfolio structure: Active (evident from targeted rebalancing), with bias toward Health Care (3 top-10 holdings) and Technology (3 top-10), but reduced exposure to mega-cap Tech/Financials. Risk appetite leans toward mid-cap growth (QXO, CHYM) over large-cap stability.
4. Per-holding one-liner:
- RPRX: Royalty Pharma (biopharma royalties)
- C: Citigroup (global bank)
- GOOGL: Alphabet (search/tech)
- AMZN: Amazon (e-commerce/cloud)
- NVDA: NVIDIA (semiconductors)
- UNH: UnitedHealth (health insurer)
- PGEN: Precigen (gene therapy)
- QXO: QXO (unverified, likely fintech/tech)
- CHYM: Chime (neobank)
- META: Meta (social media)
5. Style summary: Cautious rotation from large-cap blue chips to high-growth mid-caps, with selective cuts in Health Care/Tech and additions in fintech.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 15:21
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2023-Q3 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
This portfolio is broadly diversified (Top-10 = 47.8% of reported value), so a
Top-10 proxy cannot represent the whole fund — only the full-holdings reconstruction is shown.
Why there is no forecast NAV
Not published because:
Top-10 covers < 85% of reported value
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
RPRX · C · GOOGL · AMZN · QXO · NVDA · UNH · ET · PPLI · NCLH
2026-Q2
90%
90%
90%
RPRX · C · GOOGL · AMZN · QXO · NVDA · ET · UNH · PPLI · NCLH
RPRX · C · GOOGL · UNH · AMZN · NVDA · CVS · NCLH · QXO · ET
2026-Q3 ★
70%
70%
70%
RPRX · C · UNH · GOOGL · AMZN · NVDA · CVS · NCLH · QXO · ET
RPRX · C · GOOGL · AMZN · NVDA · UNH · PGEN · QXO · CHYM · META
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-12.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.
Portfolio return+1.20%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+12.35%vs benchmark
Barra annualised vol18.5%Model estimate
Realised vol17.7%Annualised in window
Weighted beta1.24Raw exposure
Factor / specific risk82% / 18%Share of variance
Top-10 concentration71.2%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+1.20%
Disclosed long book
QQQ synthetic benchmark
-11.15%
Liquidity-weighted constituents
Model universe, equal weight
+2.04%
Opportunity-cost reference
Excess return
+12.35%
Portfolio − benchmark
Arithmetic return sum
+1.38%
Difference vs compounded is the cross term
Weighted raw beta
1.24
Weighted holding betas
Realised volatility (annualised)
17.75%
Daily returns in window
Barra model volatility (annualised)
18.52%
Factor + specific
Factor share of variance
81.9%
Barra factors
Specific share of variance
18.1%
Stock residuals
Reported value
$1.92B
13F long US equity
2. Return attribution
The +1.38% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-3.29%
-238.6%
Momentum & Growth
3
+0.68%
49.5%
Volatility & Tail Risk
7
-0.91%
-66.0%
Industry
12
+3.26%
236.0%
Specific
1
+1.64%
119.1%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Beta
Style
+0.47
+4.92%
+2.29%
166.2%
Consumer Discretionary
Industry
+0.23
+9.36%
+2.17%
157.5%
Specific
Specific
—
—
+1.64%
119.1%
Leverage (Downside Vol)
Style
-0.30
-3.05%
+0.92%
66.8%
Health Care
Industry
+0.08
+9.47%
+0.77%
55.9%
Consumer Staples
Industry
+0.04
+14.46%
+0.63%
45.4%
Energy
Industry
+0.04
+9.91%
+0.44%
31.8%
Growth
Style
+0.23
+1.50%
+0.35%
25.2%
Momentum
Style
-0.09
-3.32%
+0.31%
22.6%
Amihud Illiquidity
Style
+0.98
+0.30%
+0.29%
21.3%
Industrials
Industry
+0.02
+3.55%
+0.09%
6.3%
Non-linear Size
Style
+0.99
+0.07%
+0.07%
4.9%
Max Drawdown
Style
+0.07
-1.01%
-0.08%
-5.5%
Financials
Industry
+0.23
-0.49%
-0.11%
-8.0%
Kurtosis
Style
-0.05
+6.17%
-0.32%
-23.2%
Information Technology
Industry
+0.35
-2.11%
-0.73%
-53.0%
Turnover
Style
+0.21
-4.35%
-0.91%
-66.0%
Residual Volatility
Style
-0.44
+2.15%
-0.95%
-68.9%
Historical Volatility
Style
+0.10
-9.82%
-0.99%
-71.8%
Size
Style
+0.64
-1.93%
-1.22%
-88.7%
Mid Cap
Style
+0.78
-1.92%
-1.50%
-108.7%
Skewness
Style
+0.37
-4.77%
-1.79%
-129.5%
3. Risk attribution
Annualised volatility is 18.52%; factor risk explains 81.9% of variance and specific risk 18.1%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Information Technology
Industry
+0.35
19.7%
+3.66%
3.7%
Beta
Style
+0.47
18.9%
+3.50%
3.5%
Specific
Specific
—
18.1%
+3.36%
3.4%
Financials
Industry
+0.23
14.0%
+2.60%
2.6%
Consumer Discretionary
Industry
+0.23
11.7%
+2.16%
2.2%
Mid Cap
Style
+0.78
6.3%
+1.18%
1.2%
Health Care
Industry
+0.08
3.6%
+0.66%
0.7%
Non-linear Size
Style
+0.99
2.7%
+0.50%
0.5%
Leverage (Downside Vol)
Style
-0.30
2.5%
+0.46%
0.5%
Consumer Staples
Industry
+0.04
2.2%
+0.41%
0.4%
Historical Volatility
Style
+0.10
2.1%
+0.38%
0.4%
Industrials
Industry
+0.02
1.5%
+0.28%
0.3%
Turnover
Style
+0.21
0.6%
+0.11%
0.1%
Growth
Style
+0.23
0.5%
+0.09%
0.1%
Energy
Industry
+0.04
0.3%
+0.06%
0.1%
Momentum
Style
-0.09
0.3%
+0.06%
0.1%
Liquidity
Style
+0.09
0.2%
+0.04%
0.0%
Kurtosis
Style
-0.05
0.2%
+0.04%
0.0%
Residual Volatility
Style
-0.44
-1.0%
-0.19%
-0.2%
Skewness
Style
+0.37
-1.2%
-0.22%
-0.2%
Amihud Illiquidity
Style
+0.98
-1.3%
-0.24%
-0.2%
Size
Style
+0.64
-1.8%
-0.33%
-0.3%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
+0.64
+2.10
-1.46
Non-linear Size
+0.99
+1.68
-0.69
Mid Cap
+0.78
+0.13
+0.66
Beta
+0.47
+1.29
-0.83
Momentum
-0.09
+0.72
-0.81
Short-term Reversal
+0.02
-0.64
+0.66
Residual Volatility
-0.44
-0.40
-0.04
Historical Volatility
+0.10
+0.86
-0.76
Liquidity
+0.09
+0.11
-0.02
Amihud Illiquidity
+0.98
+1.16
-0.18
Turnover
+0.21
+0.21
+0.00
Growth
+0.23
+0.58
-0.35
Leverage (Downside Vol)
-0.30
+0.14
-0.45
Skewness
+0.37
+0.24
+0.14
Kurtosis
-0.05
+0.21
-0.27
Max Drawdown
+0.07
-0.08
+0.16
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
34.7%
73.6%
-12.71%
-16.67%
+2.44%
+2.92%
-1.54%
+7.86%
Consumer Discretionary
23.2%
8.8%
+19.60%
+5.93%
+2.35%
+1.21%
+1.97%
+4.03%
Health Care
8.2%
1.7%
+9.77%
+9.50%
+1.28%
+0.00%
+0.02%
+0.63%
Communication Services
0.0%
2.6%
+0.00%
-12.15%
+0.05%
+0.32%
-0.32%
+0.32%
Financials
22.7%
0.0%
+0.30%
+0.00%
+2.36%
+0.00%
+0.07%
+0.07%
Consumer Staples
4.3%
0.8%
+4.47%
+15.33%
+0.90%
-0.09%
-0.38%
+0.07%
Energy
4.4%
0.1%
-0.81%
-1.54%
+0.38%
+0.00%
+0.03%
-0.03%
Utilities
0.0%
0.8%
+0.00%
+10.14%
-0.16%
-0.08%
+0.08%
-0.08%
Industrials
2.5%
11.1%
+15.45%
+7.87%
-1.58%
+0.84%
-0.66%
-0.49%
Total
+7.94%
+5.08%
-0.69%
+12.33%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
C
CITIGROUP INC
Financials
9.38%
-4.07%
-0.38%
Reduce
GOOGL
ALPHABET INC
Information Technology
9.30%
-14.71%
-1.37%
Reduce
AMZN
AMAZON COM INC
Consumer Discretionary
8.80%
+6.83%
+0.60%
Reduce
NVDA
NVIDIA CORPORATION
Information Technology
8.45%
-23.93%
-2.02%
Hold
UNH
UNITEDHEALTH GROUP INC
Health Care
8.15%
+9.77%
+0.80%
Reduce
CHYM
CHIME FINL INC
Financials
6.57%
+24.17%
+1.59%
Add
META
META PLATFORMS INC
Information Technology
6.48%
-13.30%
-0.86%
Hold
ADBE
ADOBE INC
Information Technology
5.01%
-0.97%
-0.05%
Add
NCLH
NORWEGIAN CRUISE LINE HLDGS
Consumer Discretionary
4.57%
+28.38%
+1.29%
Reduce
COIN
COINBASE GLOBAL INC
Financials
4.49%
-26.90%
-1.21%
Hold
CROX
CROCS INC
Consumer Discretionary
4.47%
+36.37%
+1.63%
Reduce
SDRL
SEADRILL LTD
Energy
4.43%
-0.81%
-0.04%
Reduce
AVGO
BROADCOM INC
Information Technology
4.37%
-1.70%
-0.07%
New
CVS
CVS HEALTH CORP
Consumer Staples
4.33%
+4.47%
+0.19%
Reduce
GPN
GLOBAL PMTS INC
Consumer Discretionary
3.99%
+22.73%
+0.91%
Reduce
GM
GENERAL MTRS CO
Industrials
2.46%
+15.46%
+0.38%
Reduce
UBS
UBS GROUP AG
Financials
1.77%
+2.60%
+0.05%
Reduce
DAL
DELTA AIR LINES INC
Consumer Discretionary
1.20%
+9.42%
+0.11%
Reduce
TEM
TEMPUS AI INC
Information Technology
1.08%
-3.02%
-0.03%
Reduce
JPM
JPMORGAN CHASE & CO
Financials
0.51%
+4.31%
+0.02%
Hold
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
CROX
Consumer Discretionary
4.47%
+36.37%
+1.63%
2
CHYM
Financials
6.57%
+24.17%
+1.59%
3
NCLH
Consumer Discretionary
4.57%
+28.38%
+1.29%
4
GPN
Consumer Discretionary
3.99%
+22.73%
+0.91%
5
UNH
Health Care
8.15%
+9.77%
+0.80%
6
AMZN
Consumer Discretionary
8.80%
+6.83%
+0.60%
7
GM
Industrials
2.46%
+15.46%
+0.38%
8
CVS
Consumer Staples
4.33%
+4.47%
+0.19%
9
C
Financials
9.38%
-4.07%
-0.38%
10
META
Information Technology
6.48%
-13.30%
-0.86%
11
COIN
Financials
4.49%
-26.90%
-1.21%
12
GOOGL
Information Technology
9.30%
-14.71%
-1.37%
13
NVDA
Information Technology
8.45%
-23.93%
-2.02%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +1.20%, versus -11.15% for the QQQ synthetic benchmark — an excess of +12.35%.
Return attribution: the largest positive style/industry contributions came from Beta +2.29%, Consumer Discretionary +2.17%, Leverage (Downside Vol) +0.92%; the largest drags came from Skewness -1.79%, Mid Cap -1.50%, Size -1.22%. Specific (stock-level) return contributed +1.64%.
Risk attribution: Barra model volatility is 18.52% annualised; factor risk explains 82% of variance and specific risk 18%. The largest factor risk sources are Information Technology 19.7%, Beta 18.9%, Financials 14.0%.
Style tilt: size +0.64, momentum -0.09, volatility +0.10, liquidity +0.09; the weighted raw beta is 1.24. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Financials (+22.7 pp), the largest underweight is Information Technology (-38.9 pp). Allocation contributed +7.94%, selection +5.08% and interaction -0.69%.
Concentration: the top-10 positions are 71.2% of the attributed portfolio and the model covers 90.7% of its value with full style exposures; the remainder is mapped to its sector only. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Patient Capital Management, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, Patient Capital Management, LLC reported 39 equity positions worth $2.96B in aggregate; its largest disclosed positions were RPRX ($199.71M), C ($179.92M), GOOGL ($178.40M).
How large is Patient Capital Management, LLC's portfolio?
Patient Capital Management, LLC reported $2.96B of long equity holdings across 39 positions as of 2026-Q3. Top-10 holdings account for 53.3% of reported value.
What is Patient Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/patient-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>